A recent article in JAMA Internal Medicine describes a common genetic mutation found in many breast cancer patients who do ...

More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...

Researchers have demonstrated in the WISDOM trial that integrating criteria-independent genetic testing into routine breast ...

Researchers at Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center and Human Genome Sequencing Center investigated the extent to which forms of genetic variation called germline or ...

Authors from Facing Our Risk of Cancer Empowered (FORCE), a nonprofit organization focused on hereditary cancer, discuss the importance of genetic testing, guidelines, and coverage considerations.

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations The study population included 15,104 prospectively ...

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional ...

BOSTON & EL MONTE, Calif., February 04, 2025--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced plans to launch two new germline ...

Genome editing is as consequential as it is controversial. The ability to modify a person’s genes to add or remove particular physical traits is moving from science fiction to science fact: already ...